Yarden Y - Search Results

1

Expression of the erbB-2 family of growth factor receptors and their ligands in breast cancers. Implication for tumor biology and clinical behavior.

Bacus SS, Zelnick CR, Plowman G, Yarden Y. Bacus SS, et al. Among authors: yarden y. Am J Clin Pathol. 1994 Oct;102(4 Suppl 1):S13-24. Am J Clin Pathol. 1994. PMID: 7942609 Review.

2

Medullary carcinoma is associated with expression of intercellular adhesion molecule-1. Implication to its morphology and its clinical behavior.

Bacus SS, Zelnick CR, Chin DM, Yarden Y, Kaminsky DB, Bennington J, Wen D, Marcus JN, Page DL. Bacus SS, et al. Among authors: yarden y. Am J Pathol. 1994 Dec;145(6):1337-48. Am J Pathol. 1994. PMID: 7992839 Free PMC article.

3

Type 1 receptor tyrosine kinases are differentially phosphorylated in mammary carcinoma and differentially associated with steroid receptors.

Bacus SS, Chin D, Yarden Y, Zelnick CR, Stern DF. Bacus SS, et al. Among authors: yarden y. Am J Pathol. 1996 Feb;148(2):549-58. Am J Pathol. 1996. PMID: 8579117 Free PMC article.

4

Neu differentiation factor (Heregulin) activates a p53-dependent pathway in cancer cells.

Bacus SS, Yarden Y, Oren M, Chin DM, Lyass L, Zelnick CR, Kazarov A, Toyofuku W, Gray-Bablin J, Beerli RR, Hynes NE, Nikiforov M, Haffner R, Gudkov A, Keyomarsi K. Bacus SS, et al. Among authors: yarden y. Oncogene. 1996 Jun 20;12(12):2535-47. Oncogene. 1996. PMID: 8700512

5

Expression of erbB receptors and their ligands in breast cancer: implications to biological behavior and therapeutic response.

Bacus SS, Gudkov AV, Esteva FJ, Yarden Y. Bacus SS, et al. Among authors: yarden y. Breast Dis. 2000;11:63-75. doi: 10.3233/bd-1999-11106. Breast Dis. 2000. PMID: 15687593

6

Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.

Bacus SS, Stancovski I, Huberman E, Chin D, Hurwitz E, Mills GB, Ullrich A, Sela M, Yarden Y. Bacus SS, et al. Among authors: yarden y. Cancer Res. 1992 May 1;52(9):2580-9. Cancer Res. 1992. PMID: 1373672

7

An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.

Chen X, Levkowitz G, Tzahar E, Karunagaran D, Lavi S, Ben-Baruch N, Leitner O, Ratzkin BJ, Bacus SS, Yarden Y. Chen X, et al. Among authors: yarden y. J Biol Chem. 1996 Mar 29;271(13):7620-9. J Biol Chem. 1996. PMID: 8631797 Free article.

8

The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.

Pinkas-Kramarski R, Lenferink AE, Bacus SS, Lyass L, van de Poll ML, Klapper LN, Tzahar E, Sela M, van Zoelen EJ, Yarden Y. Pinkas-Kramarski R, et al. Among authors: yarden y. Oncogene. 1998 Mar 12;16(10):1249-58. doi: 10.1038/sj.onc.1201642. Oncogene. 1998. PMID: 9546426

9

ErbB tyrosine kinases and the two neuregulin families constitute a ligand-receptor network.

Pinkas-Kramarski R, Shelly M, Guarino BC, Wang LM, Lyass L, Alroy I, Alimandi M, Kuo A, Moyer JD, Lavi S, Eisenstein M, Ratzkin BJ, Seger R, Bacus SS, Pierce JH, Andrews GC, Yarden Y. Pinkas-Kramarski R, et al. Among authors: yarden y. Mol Cell Biol. 1998 Oct;18(10):6090-101. doi: 10.1128/MCB.18.10.6090. Mol Cell Biol. 1998. PMID: 9742126 Free PMC article.

10

Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.

Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP, Keyomarsi K, Yarden Y, Seger R. Bacus SS, et al. Among authors: yarden y. Oncogene. 2001 Jan 11;20(2):147-55. doi: 10.1038/sj.onc.1204062. Oncogene. 2001. PMID: 11313944

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

353 results

Search Page

Filters